FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

725786001: Cilazapril monohydrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3445300016 Cilazapril monohydrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3445301017 Cilazapril monohydrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
800821000172111 cilazapril monohydraté fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cilazapril monohydrate (substance) Is a Cilazapril (substance) false Inferred relationship Some
Cilazapril monohydrate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Angiotensin-converting enzyme inhibitor (disposition) true Inferred relationship Some
Cilazapril monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Cilazapril (substance) true Inferred relationship Some
Cilazapril monohydrate (substance) Is a Heterocyclic compound true Inferred relationship Some
Cilazapril monohydrate (substance) Is a Angiotensin-converting enzyme inhibitor true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely cilazapril (as cilazapril monohydrate) 1 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Cilazapril monohydrate (substance) Inferred relationship Some 1
Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Cilazapril monohydrate (substance) Inferred relationship Some 1
Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Cilazapril monohydrate (substance) Inferred relationship Some 1
Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Cilazapril monohydrate (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start